Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cardiac failure is a frequent cause of death in the aging human population. Telomere attrition occurs with age, and is proposed to be causal for the aging process. To determine whether telomere shortening leads to a cardiac phenotype, we studied heart function in the telomerase knockout mouse, Terc-/-. We studied Terc-/- mice at the second, G2, and fifth, G5, generation. Telomere shortening in G2 and G5 Terc-/- mice was coupled with attenuation in cardiac myocyte proliferation, increased apoptosis and cardiac myocyte hypertrophy. On a single-cell basis, telomere shortening was coincidental with increased expression of p53, indicating the presence of dysfunctional telomeres in cardiac myocytes from G5 Terc-/- mice. The impairment in cell division, the enhanced cardiac myocyte death and cellular hypertrophy, are concomitant with ventricular dilation, thinning of the wall and cardiac dysfunction. Thus, inhibition of cardiac myocyte replication provoked by telomere shortening, results in de-compensated eccentric hypertrophy and heart failure in mice. Telomere shortening with age could also contribute to cardiac failure in humans, opening the possibility for new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The telomerase-knockout mouse has provided an important model for understanding telomere-mediated disease mechanisms because there is a remarkable convergence with human disease phenotypes (an overview is shown in Table 2)36,82,84,85,97,99–111.”
From The telomere syndromes (2012) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, mice carrying a homozygous germline deletion of the telomerase RNA component gene (Terc−/−) exhibit critically short telomeres and a premature development of age-related pathologies from the second or third generation [8, 18–20, 51, 70, 72, 101, 103]”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Late-generation telomerase-deficient mice show severe left ventricular loss of function, increased cardiomyocyte hypertrophy and decreased number of cardiomyocytes111.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [111]
The cited source says what the claim attributes to it.
In the citing paper
“more recently it has been recognized that telomere dysfunction causes prominent phenotypes in slow-turnover tissues97,99,100,103 (Table 2).”
From The telomere syndromes (2012) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationMobilized bone marrow cells repair the infarcted heart, improving function and survival
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., & Anversa, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181177898 · Cited by 2,086
Self-citationEvidence That Human Cardiac Myocytes Divide after Myocardial Infarction
Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S.-M., Finato, N., Bussani, R., Nadal-Ginard, B., Silvestri, F., Leri, A., Beltrami, C. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442303 · Cited by 1,429
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Self-citationChimerism of the Transplanted Heart
Quaini, F., Urbanek, K., Beltrami, A. P., Finato, N., Beltrami, C. A., Nadal-Ginard, B., Kajstura, J., Leri, A., & Anversa, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012081 · Cited by 1,264
Self-citationHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Research works printed but not linked: 1
- Anversa P. and Olivetti,G. (2001) Cellular basis of physiologic myocardial growth. In Page,E., Fozzard,H. and Solaro,J. (eds), Handbook of Physiology, Section 2: The Cardiovascular System, Volume I: The Heart. Oxford University Press, New York, NY, 75–144.
Cited by
Items 101–200 of 312
Increased telomerase activity and vitamin D supplementation in overweight African Americans
Zhu, H., Guo, D., Li, K., Pedersen-White, J., Stallmann-Jorgensen, I. S., Huang, Y., Parikh, S., Liu, K., & Dong, Y. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.197 · Cited by 75
Aging, telomeres and heart failure
Wong, L. S. M., van der Harst, P., de Boer, R. A., Huzen, J., van Gilst, W. H., & van Veldhuisen, D. J. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9173-7 · Cited by 75
“Fifth-generation telomerase knockout mice have severely reduced telomere length and suffer from severe left ventricular failure, characterized by increased end-diastolic left ventricular pressure, decreased maximally developed left ventricular pressure and disturbed relaxation and contractility very similar to that ob…”
BackgroundThe Young Mouse Heart Is Composed of Myocytes Heterogeneous in Age and Function
Rota, M., Hosoda, T., De Angelis, A., Arcarese, M. L., Esposito, G., Rizzi, R., Tillmanns, J., Tugal, D., Musso, E., Rimoldi, O., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.151449 · Cited by 75
“An FITC-peptide nucleic acid probe was used (2, 5-7).”
MethodSelf-citationp53: at the crossroad between cancer and ageing
Papazoglu, C., & Mills, A. (2007) · The Journal of Pathology · doi:10.1002/path.2086 · Cited by 72
Functional Role of Calstabin2 in Age-related Cardiac Alterations
Yuan, Q., Chen, Z., Santulli, G., Gu, L., Yang, Z.-G., Yuan, Z.-Q., Zhao, Y.-T., Xin, H., Deng, K.-Y., Wang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07425 · Cited by 76
Martínez, P., & Blasco, M. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312202 · Cited by 82
“Adult mice deficient for telomerase with critically short telomeres develop cardiomyopathy characterized by impaired cell division, enhanced cardiomyocyte death, and cellular hypertrophy, which are concomitant with ventricular dilatation, thinning of the wall, and cardiac dysfunction.(76) This observation has led to t…”
BackgroundSelf-citationLiu, J., & Li, H. (2010) · Reproduction · doi:10.1530/rep-10-0008 · Cited by 81
“Knock out in mice of TERT (Leri et al .”
BackgroundTelomerase expression in the mammalian heart
Richardson, G. D., Breault, D., Horrocks, G., Cormack, S., Hole, N., & Owens, W. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-208843 · Cited by 70
“As such activity is typically related to pathways of cell survival, this too would be consistent with the increase in expression following injury (36, 42).”
BackgroundTelomere length and cardiovascular disease
Saliques, S., Zeller, M., Lorin, J., Lorgis, L., Teyssier, J., Cottin, Y., Rochette, L., & Vergely, C. (2010) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.08.002 · Cited by 79
Apolipoprotein E, an important player in longevity and age-related diseases
Ang, L. S., Cruz, R. P., Hendel, A., & Granville, D. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.03.010 · Cited by 76
“Without the ability to maintain telomere length Terc-null mice exhibited premature-aging symptoms such as hair greying, alopecia, infertility, heart dysfunction and various tissue atrophies (Leri et al., 2003; Rudolph et al., 1999).”
Telomeres, telomerase, and apoptosis
Mondello, C., & Scovassi, A. I. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-048 · Cited by 73
The (pro)renin receptor in health and disease
Nguyen, G. (2010) · Annals of Medicine · doi:10.3109/07853890903321567 · Cited by 65
Siegl-Cachedenier, I., Flores, I., Klatt, P., & Blasco, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704141 · Cited by 64
“…these defects are anticipated with subsequent Terc−/− mouse generations with progressively shorter telomeres concomitant with premature loss of tissue regeneration and organismal survival (Lee et al., 1998; Herrera et al., 1999; Leri et al., 2003; Flores et al., 2005; García-Cao et al., 2006).”
Self-citationTelomerase as a Therapeutic Target in Cardiovascular Disease
Hoffmann, J., Richardson, G. D., Haendeler, J., Altschmied, J., Andrés, V., & Spyridopoulos, I. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315695 · Cited by 73
Telomere dysfunction in hypertension
Fuster, J. J., Díez, J., & Andrés, V. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ef6196 · Cited by 67
“transgenic mice [70] Late-generation TERC-null mice with critically short telomeres [ 27 ] Wildtype mice [62]”
BackgroundPillai, V. B., Samant, S. A., Hund, S., Gupta, M., & Gupta, M. P. (2021) · Aging · doi:10.18632/aging.203027 · Cited by 64
“In the Tert −/− and Terc −/− mice, telomere dysfunction induces mitochondrial defects, leading to cardiac aging and heart failure [44, 70].”
Imamura, S., Uchiyama, J., Koshimizu, E., Hanai, J.-I., Raftopoulou, C., Murphey, R. D., Bayliss, P. E., Imai, Y., Burns, C. E., Masutomi, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003364 · Cited by 58
“TERT-deficient and control embryos at 24 hpf were hybridized with a Cy3-labeled peptide nucleic acid (PNA) telomere-specific probe as described in the Materials and Methods [59,60].”
MethodTelomere Biology in Heart Failure
Wong, L. S. M., de Boer, R. A., Samani, N. J., van Veldhuisen, D. J., & van der Harst, P. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.007 · Cited by 58
“es, lead to myocyte apoptosis, decreased cardiomyocyte number, iac myocyte proliferation, myocyte hypertrophy, decreased +dP/dt, evated LVend-diastolic pressure, development dilated cardiomyopathy, [69]”
BackgroundTelomere length and cardiovascular disease risk
Zhan, Y., & Hägg, S. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000613 · Cited by 57
Telomere, aging and age-related diseases
Huang, X., Li, C., Ren, F., Zhang, H., & Zhang, L. (2013) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0021-1 · Cited by 66
“Telomere shortening with age might also contribute to cardiac failure in humans, opening the possibility for new therapies [50].”
BackgroundModeling Hypertrophic IP3 Transients in the Cardiac Myocyte
Cooling, M. T., Hunter, P. J., & Crampin, E. J. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.110031 · Cited by 55
Telomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 70
“…30,215 , pulmonary 109,110,172,216 and haematopoietic stem cell ageing 29,30,108,217 , metabolic 112,113 and gastro-intestinal ageing 30,215 , cardiovascular 111 and skeletal diseases 218,219 , renal dysfunction 220,221 , neurodegenerative conditions 213,222 and decline in fertility 29,30,223 .”
Strahl, J., & Abele, D. (2010) · Marine Biology · doi:10.1007/s00227-010-1408-6 · Cited by 55
“Impaired cardiac function has been suggested to limit life span in mammals (Leri et al. 2003) and perhaps ‘heart failure’ could finally cause natural death in old ocean quahog.”
Association Between Left Ventricular Mass and Telomere Length in a Population Study
Kuznetsova, T., Codd, V., Brouilette, S., Thijs, L., Gonzalez, A., Jin, Y., Richart, T., van der Harst, P., Diez, J., Staessen, J. A., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq142 · Cited by 54
Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps
Broughton, K. M., & Sussman, M. A. (2016) · Circulation Research · doi:10.1161/circresaha.115.305227 · Cited by 59
Sheng, R., Gu, Z., Xie, M., Wen-xuan, Z., & Ci-yi, G. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.054 · Cited by 53
“Evidences showed that the tumor suppressor protein p53 could mediate telomere dysfunction (Leri et al., 2003; Sano et al., 2007).”
BackgroundTelomeres as Therapeutic Targets in Heart Disease
Yeh, J.-K., Lin, M.-H., & Wang, C.-Y. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.009 · Cited by 49
“Mice with genetic knockout of TERC or TERT had progressively shorter telomeres over generations and showed features such as severe developmental defects, aging pathologies, and premature death (38).”
BackgroundLong noncoding RNA in cardiac aging and disease
Lozano‐Vidal, N., Bink, D. I., & Boon, R. A. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz046 · Cited by 53
Canela, A., Klatt, P., & Blasco, M. A. (2007) · Methods in Molecular Biology · doi:10.1007/978-1-59745-361-5_5 · Cited by 49
Self-citationKajstura, J., Bolli, R., Sonnenblick, E. H., Anversa, P., & Leri, A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.12.013 · Cited by 53
Self-citationCriscuolo, F., Smith, S., Zahn, S., Heidinger, B. J., & Haussmann, M. F. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0440 · Cited by 50
Views From Within and Beyond: Narratives of Cardiac Contractile Dysfunction Under Senescence
Yang, X., Sreejayan, N., & Ren, J. T. (2005) · Endocrine · doi:10.1385/endo:26:2:127 · Cited by 51
Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge
Siddiqi, S., Gude, N. A., Hosoda, T., Muraski, J. A., Rubio, M., Emmanuel, G. N., Fransioli, J., Vitale, S., Parolin, C., D’Amario, D., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.169334 · Cited by 51
Self-citationShen, L., Chen, C., Wei, X., Li, X., Luo, G., Zhang, J., Bin, J., Huang, X., Cao, S., Li, G., et al. (2014) · Clinical Science · doi:10.1042/cs20140586 · Cited by 47
Cardiac System during the Aging Process
Fernandes-Ribeiro, A. S., Zerolo, B. E., López‐Espuela, F., Sanchez, R., & Fernandes, V. S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0115 · Cited by 86
“coronary heart disease and in a lesser extend for cerebrovascular [158].”
BackgroundSuelves, N., Saleki, S., Ibrahim, T., Palomares, D., Moonen, S., Koper, M. J., Vrancx, C., Vadukul, D. M., Papadopoulos, N., Viceconte, N., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01578-x · Cited by 43
Telomeres, Aging and Exercise: Guilty by Association?
Chilton, W., O’Brien, B. J., & Charchar, F. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122573 · Cited by 49
Makino, N., Maeda, T., Oyama, J., Sasaki, M., Higuchi, Y., Mimori, K., & Shimizu, T. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.014 · Cited by 44
“Both telomerase and TERT have been shown to regulate cardiac muscle cell growth and survival [17], and their loss causes cardiac dysfunction, increased expression of p53, and increased apoptosis [18].”
BackgroundCardiovascular aging: from cellular and molecular changes to therapeutic interventions
Vakka, A., Warren, J. S., & Drosatos, K. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.09 · Cited by 70
Cottage, C. T., Neidig, L., Sundararaman, B., Din, S., Joyo, A. Y., Bailey, B., Gude, N., Hariharan, N., & Sussman, M. A. (2012) · STEM CELLS · doi:10.1002/stem.1211 · Cited by 40
Muñoz-Lorente, M. A., Martínez, P., Tejera, Á., Whittemore, K., Moisés-Silva, A. C., Bosch, F., & Blasco, M. A. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007562 · Cited by 40
Self-citationTelomere length and outcome in heart failure
van der Harst, P., de Boer, R. A., Samani, N. J., Wong, L. S. M., Huzen, J., Codd, V., Hillege, H. L., Voors, A. A., van Gilst, W. H., Jaarsma, T., et al. (2010) · Annals of Medicine · doi:10.3109/07853890903233887 · Cited by 40
The emerging role of telomere biology in cardiovascular disease
Huzen, J., de Boer, R. A., van Veldhuisen, D. J., van Gilst, W. H., & van der Harst, P. (2009) · Frontiers in bioscience · doi:10.2741/3604 · Cited by 42
Aging and atrial fibrillation: A vicious circle
Gao, P., Gao, X., Xie, B., Tse, G., & Liu, T. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131445 · Cited by 44
Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
Cianflone, E., Torella, M., Chimenti, C., Angelis, A. D., Beltrami, A. P., Urbanek, K., Rota, M., & Torella, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5813147 · Cited by 41
“This conclusion is further strengthened by the normal structural organization and functional activity of CMs generated in vivo in response to CSC transplantation after cardiac injury in rodents [44, 55, 62, 63].”
BackgroundMethodInfluentialAging and the programmed death phenomena
Skulachev, V. P. (2003) · Topics in current genetics · doi:10.1007/978-3-540-37005-5_8 · Cited by 48
Role of Telomerase in the Cardiovascular System
Zurek, M., Altschmied, J., Kohlgrüber, S., Ale-Agha, N., & Haendeler, J. (2016) · Genes · doi:10.3390/genes7060029 · Cited by 36
“Those alterations led to thinning of the ventricle wall, left ventricular dilatation and impaired cardiac performance [13].”
BackgroundAkasheva, D. U., Владимировна, П. Е., Ткачева, О. Н., Strazhesko, I. D., Dudinskaya, Е. N., Сергеевна, К. А., Pykhtina, V. S., Brailova, N. V., Pokshubina, I. A., Шарашкина, Н. В., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135883 · Cited by 36
“In mouse with shorter telomeres were observed a decrease of left ventricular mass, impaired relaxation and ventricular contractility, as well as the development of heart failure [3].”
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure
Aung, N., Wang, Q., van Duijvenboden, S., Burns, R., Stoma, S., Raisi‐Estabragh, Z., Ahmet, S., Allara, E., Wood, A., Angelantonio, E. D., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.2167 · Cited by 38
Molecular basis of functional myogenic specification ofBona Fidemultipotent adult cardiac stem cells
Cianflone, E., Aquila, I., Scalise, M., Marotta, P., Torella, M., Nadal‐Ginard, B., & Torella, D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1464852 · Cited by 36
“decompensated eccentric hypertrophy and heart failure [158].”
BackgroundInfluentialSelf-citationCardiac telomere length in heart development, function, and disease
Booth, S. A., & Charchar, F. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2017 · Cited by 39
“The most common explanation for this phenomenon is oxidative stress (2, 48, 79, 155), and several findings support this suggestion.”
BackgroundInfluentialTelomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases
Hong, J., & Yun, C. (2019) · Cells · doi:10.3390/cells8050392 · Cited by 35
“A telomerase-deficient TG mouse with telomere attrition developed cardiomyopathy and exhibited impaired cell division, greater cardiomyocyte death, and cellular hypertrophy, leading to various cardiac dysfunctions [22].”
BackgroundMitochondrial Dysfunction Contributes to Aging‐Related Atrial Fibrillation
Liu, C., Bai, J., Dan, Q., Yang, X. Y., Lin, K., Fu, Z., Xu, L., Xie, X., Liu, J., Li, F., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5530293 · Cited by 34
“Researchers had also found that the telomere of left ventricular cardiomyocytes of TERC mice at 6-8 months was shorter than that of 2-4 months (P < 0:0001); further, the expression of p53 was higher, while the expression of PGC was lower [38].”
BackgroundThe Telomere–Telomerase Axis and the Heart
Kajstura, J., Rota, M., Urbanek, K., Hosoda, T., Bearzi, C., Anversa, P., Bolli, R., & Leri, A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2125 · Cited by 34
Self-citationTelomeres and telomerase in risk assessment of cardiovascular diseases
Boniewska-Bernacka, E., Pańczyszyn, A., & Klinger, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112361 · Cited by 31
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
“…or telomere shortening, for example, induces an early-onset cardiovascular aging phenotype in mice, characterized by premature myocardial hypertrophy, fibrosis, and diastolic dysfunction, as well as vascular oxidative stress, endothelial dysfunction, and increased blood pressure [172,173].”
BackgroundCharacteristics of cardiac aging in C57BL/6 mice
Cheng, Z., Ito, S., Nishio, N., Thanasegaran, S., He, F., & Isobe, K. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.01.005 · Cited by 34
“In Tert−/− and Terc−/−mice, telomere dysfunction induces p53 expression, thereby causing metabolic and mitochondrial compromise (Sahin et al., 2011), as well as cardiac aging and heart failure (Leri et al., 2003; Nilsson, 2012; Wong et al., 2009).”
BackgroundDas, B., Young, D., Vasanji, A., Gupta, S., Sarkar, S., & Sen, S. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq068 · Cited by 31
“Leri et al.(5) demonstrated an association of p53 upregulation with HF.”
RetractedWątroba, M., Maślińska, D., & Maśliński, S. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0039-1 · Cited by 34
Denham, J. (2023) · Aging Cell · doi:10.1111/acel.13836 · Cited by 28
Prevention of heart failure in the elderly: when, where and how to begin?
Jugdutt, B. I. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9299-x · Cited by 28
“mice develop short telomeres and HF [123], suggesting that telomere shortening with aging contributes to HF and may be targeted for therapy.”
BackgroundHaver, V. G., Leach, I. M., KJEKSHUS, J. K., Fox, J. C., Wedel, H., Wikstrand, J., de Boer, R. A., van Gilst, W. H., McMurray, J. J. V., van Veldhuisen, D. J., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.237 · Cited by 28
“Habitual smoker (%) 94 (12) 66 (8) 53 (7) 58 (7) 271 (8)”
Denil, S. L. I. J., Rietzschel, E. R., Buyzere, M. D., daele, C. M. V., Segers, P., Bacquer, D. D., Criekinge, W. V., Bekaert, S., Gillebert, T. C., Meyer, T. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115071 · Cited by 27
“As a matter of fact, in mice, knock-out of the telomere elongating enzyme telomerase, resulted in shortened telomere length over several generations which was associated with the development of overt chronic HF [45].”
BackgroundDagher, O., Mury, P., Noly, P., Fortier, A., Lettre, G., Thorin, É., & Carrier, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.741542 · Cited by 30
Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling
Ebeid, D. E., Khalafalla, F. G., Broughton, K. M., Monsanto, M. M., Esquer, C., Sacchi, V., Hariharan, N., Korski, K., Moshref, M., Emathinger, J. M., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa066 · Cited by 26
Eguchi, A., Gonzalez, A. F. G. S., Torres-Bigio, S. I., Koleckar, K., Birnbaum, F., Zhang, J. Z., Wang, V. Y., Wu, J. C., Artandi, S. E., & Blau, H. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209967120 · Cited by 25
Telomeres, cell senescence and human ageing
von Zglinicki, T., Martin-Ruiz, C. M., & Saretzki, G. C. (2005) · Signal Transduction · doi:10.1002/sita.200400049 · Cited by 28
Liu, J., Wang, Y., Cui, J., Sun, M., Pu, Z., Wang, C., Du, W., Liu, X., Wu, J., Hou, J., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0515-4 · Cited by 23
“Meanwhile, the upregulation of p53 may be critical in the modulation of heart failure [20, 21], and has also been shown to activate the miR199a-3p expression at the post-transcriptional level in induced pluripotent stem cells (iPSCs) [22].”
BackgroundLi, B., Xiong, W., Zuo, W., Shi, Y., Wang, T., Chang, L., Wu, Y., Ma, H., Bian, Q., & Chang, A. C. Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae274 · Cited by 27
“Propagation of TERT-or TERC-deficient mice to induce systemic short telomeres is sufficient to drive the onset of dilated cardiomyopathy in mice ( 25 ,26 ).”
Cellular Senescence, Inflammaging and Cardiovascular Disease
Zanders, L., Arifaj, D., Wagner, J. U. G., & Dimmeler, S. (2026) · Immunological Reviews · doi:10.1111/imr.70084 · Cited by 33
“Interestingly, the murine senescence models bearing progeria-driver mutations or telomerase deficiency typically die from heart failure [58, 59] and patients with Hutchinson-Gilford Progeria Syndrome develop early and severe atherosclerotic disease, which is the primary cause of death in these…”
Telomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
Iskandar, M., Barbero, M. X., Jaber, M. T., Chen, R., Gomez-Guevara, R., Cruz, E., & Westerheide, S. D. (2025) · Cancers · doi:10.3390/cancers17020257 · Cited by 34
Oestrogen, telomerase, ovarian ageing and cancer
Li, H., Simpson, E. R., & Liu, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05238.x · Cited by 26
Matsumoto, C., Jiang, Y., Emathinger, J. M., Quijada, P. J., Nguyen, N., Torre, A. D. L., Moshref, M., Nguyen, J. T., Levinson, A. B., Shin, M., et al. (2018) · Stem Cells · doi:10.1002/stem.2793 · Cited by 22
Zou, A., Xiao, T., Chi, B., Wang, Y., Mao, L., Cai, D., Gu, Q., Chen, Q., Wang, Q., Ji, Y., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s454277 · Cited by 24
Role of Cellular Senescence in Lifestyle-Related Disease
Minamino, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0916 · Cited by 21
Booth, L. K., Redgrave, R. E., Tual‐Chalot, S., Spyridopoulos, I., Phillips, H. M., & Richardson, G. D. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_4 · Cited by 21
Vo, T. K. D., de Saint‐Hubert, M., Morrhaye, G., Godard, P., Geenen, V. G., Martens, H., Debacq‐Chainiaux, F., Swine, C., & Toussaint, O. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.02.002 · Cited by 19
“Several studies in animal models provided pathophysiological insights into the role of telomeres in heart failure (Leri et al., 2003; Oh et al., 2003).”
Epigenetic Regulation of Telomere Chromatin Integrity in Pluripotent Embryonic Stem Cells
Wong, L. H. (2010) · Epigenomics · doi:10.2217/epi.10.49 · Cited by 23
Vigneault, P., Naud, P., Qi, X., Xiao, J., Villeneuve, L. R., Davis, D. R., & Nattel, S. (2018) · The Journal of Physiology · doi:10.1113/jp275388 · Cited by 22
“Loss of c-Kit+ eCPC function promotes cardiomyocyte ageing and emergence of a senescent phenotype (Leri et al. 2003; Gonzalez et al. 2008).”
BackgroundTelomeres and telomerase in heart regeneration
Aix, E., Gallinat, A., & Flores, I. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.003 · Cited by 20
The Importance of Cellular Senescence in Frailty and Cardiovascular Diseases
Boccardi, V., & Mecocci, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-33330-0_9 · Cited by 25
Raymond, A. R., Norton, G. R., Sareli, P., Woodiwiss, A. J., & Brooksbank, R. L. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs147 · Cited by 22
“Importantly, genetic knockout of the telomerase enzyme in mice is associated with telomere attrition and the development of overt heart failure in subsequent generations.(5)”
BackgroundAging Effects on Cardiac Progenitor Cell Physiology
Rota, M., Goichberg, P., Anversa, P., & Leri, A. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140082 · Cited by 23
Self-citationDistinct roles of telomerase activity in age-related chronic diseases: An update literature review
Wang, X., Deng, H., Lin, J., Zhang, K., Ni, J., Li, L., & Fan, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115553 · Cited by 21
Effect of Chronic Ethanol Ingestion and Gender on Heart Left Ventricular p53 Gene Expression
l, H. J. N., Eriksson, P., Eklund, K. K., Sarviharju, M., H�rk�nen, M., & ki, T. M. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000175043.67463.e5 · Cited by 17
Telomere dynamics during aging in polygenic left ventricular hypertrophy
Marques, F. Z., Booth, S. A., Prestes, P. R., Curl, C. L., Delbridge, L. M. D., Lewandowski, P. A., Harrap, S. B., & Charchar, F. J. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00083.2015 · Cited by 19
Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models
Franco, S., Canela, A., Klatt, P., & Blasco, M. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi107 · Cited by 28
Self-citationPygopus Maintains Heart Function in Aging Drosophila Independently of Canonical Wnt Signaling
Tang, M., Yuan, W., Fan, X., Liu, M., Bodmer, R., Ocorr, K. A., & Wu, X. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000253 · Cited by 17
Telomeres and Telomerase in Heart Ontogenesis, Aging and Regeneration
Nalobin, D. S., Alipkina, S. I., Gaidamaka, A., Glukhov, A. I., & Khuchua, Z. A. (2020) · Cells · doi:10.3390/cells9020503 · Cited by 17
“These results are consistent with the notion that telomere loss in mice activates p53, which modulates both apoptosis and growth arrest [47].”
BackgroundResultCardiac Aging – Benefits of Exercise, Nrf2 Activation and Antioxidant Signaling
Narasimhan, M., & Rajasekaran, N. S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4307-9_13 · Cited by 18
Cardiac aging: Molecular mechanisms and therapeutic interventions
Li, X., Pang, X., Sun, H., Zhang, B., Wang, H., Wu, N., & Yang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107954 · Cited by 21
Role of stem cells in cardiovascular biology
Hosoda, T., Rota, M., Kajstura, J., Leri, A., & Anversa, P. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04363.x · Cited by 18
Self-citationTelomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
Huang, Y., & Wang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189867 · Cited by 15
“Furthermore, telomere length is shorter than usual in patients with congestive heart failure [48,49].”
BackgroundStem cell therapy for cardiac regeneration: hits and misses
Padda, J., Sequiera, G. L., Sareen, N., & Dhingra, S. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0468 · Cited by 15
“The answer to lasting restoration of infarcted heart lies in addressing the mechanism behind the actual insult to the heart tissue, which is the progressive lossof cardiomyocytes (CMs) (Saraste et al. 1999; Leri et al. 2003).”
BackgroundRenal failure induces telomere shortening in the rat heart
Wong, L. S. M., Windt, W. A. K. M., Roks, A. J. M., van Dokkum, R. P., Schoemaker, R. G., de Zeeuw, D., & Henning, R. H. (2009) · Netherlands Heart Journal · doi:10.1007/bf03086245 · Cited by 14
Expanding the Concept of Telomere Dysfunction in Cardiovascular Disease
van der Harst, P., van Veldhuisen, D. J., & Samani, N. J. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164434 · Cited by 14
Cardiac Stem Cells for Myocardial Regeneration
Nadal‐Ginard, B., & Méndez‐Ferrer, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-30939-x_3 · Cited by 12
Self-citationAGE-RELATED CHANGES IN HEART RATE VARIABILITY AND THEIR RELATION WITH LEUCOCYTE TELOMERE LENGTH
Streltsova, L. I., Tkacheva, О. N., Владимировна, П. Е., Akasheva, D. U., Strajesko, I. D., Dudinskaya, Е. N., & Boytsov, S. A. (2017) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2017-1-54-60 · Cited by 14
Telomere length is independently associated with all-cause mortality in chronic heart failure
Romaine, S. P. R., Denniff, M. J., Codd, V., Nath, M., Koekemoer, A. L., Anker, S. D., Cleland, J. G. F., Filippatos, G. S., Levin, D., Metra, M., et al. (2021) · Heart · doi:10.1136/heartjnl-2020-318654 · Cited by 14
Metadata
- Authors
- Leri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal‐Ginard, B., Kajstura, J., Anversa, P., & Blasco, M. A.
- Affiliations
- New York Medical College (US)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- The EMBO Journal
- Published
- 2003-01-02
- Volume
- 22
- Issue
- 1
- Pages
- 131-139
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC140062
- OpenAlex
- W1996380574
- Cited by
- 313
- References
- 32
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 10 · 2023: 16 · 2022: 5 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 17 · 2017: 15 · 2016: 7 · 2015: 15 · 2014: 12 · 2013: 14 · 2012: 19
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-15756, R01AG017042, R01AG015756, AG17042)
- National Heart, Lung, and Blood Institute (HL65573, HL65577, R01HL039902, R01HL066923, HL39902, HL 38132, HL-66923, R01HL065573, R01HL065577, R01HL038132)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- telomere shortening, telomerase, heart failure, cardiac dilatation, p53 upregulation, cardiomyocyte proliferation, apoptosis, cardiac hypertrophy, eccentric hypertrophy, aging
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Gene Expression Regulation, Heart, Heart Failure, Humans, Vasodilation, Genes, p53, Tumor Suppressor Protein p53, Telomere, Mice, Knockout, Telomerase, Muscle Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.